Caricamento...
Engineering of a self-adjuvanted iTEP-delivered CTL vaccine
Cytotoxic T lymphocyte (CTL) epitope peptide-based vaccines are widely used in cancer and infectious disease therapy. We previously generated an immune-tolerant elastin-like polypeptides (iTEPs)-based carrier to deliver a peptide CTL vaccine and enhance the efficiency of the vaccine. To further opti...
Salvato in:
| Pubblicato in: | Acta Pharmacol Sin |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Nature Publishing Group
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5520189/ https://ncbi.nlm.nih.gov/pubmed/28414197 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/aps.2017.31 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|